Used in pharmaceutical research as a key intermediate in the synthesis of sigma receptor ligands, particularly targeting the sigma-1 receptor subtype. Its structure enables high affinity binding, making it valuable in developing treatments for neurological disorders such as neuropathic pain, depression, and neurodegenerative diseases. Also explored in oncology for potential antitumor activity due to its ability to modulate cellular signaling pathways involved in apoptosis and proliferation. The chloro and hydroxypropylamino groups allow further chemical modifications, enhancing its utility in structure-activity relationship studies.